This information was published on 2026-02-26T06:42:51 for IP Right Filed Published.
| Field | Value |
| (210) | 2630638 (IR 1904001) |
| (220) |
19 Jan 2026
|
| (300) |
KR, 29 Jul 2025, 4020250137830
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of inflammatory diseases. |
| (540) | OLYMAVUS |
| (550) | Word |
| (730) |
CELLTRION, INC.
|
Find out more about publications on the About page.